Transamerica Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59K | Buy |
856
+106
| +14% | +$7.31K | 0.01% | 302 |
|
|
2025
Q1 | $53K | Sell |
750
-74
| -9% | -$5.23K | 0.01% | 305 |
|
|
2024
Q4 | $71K | Sell |
824
-73
| -8% | -$6.29K | 0.01% | 286 |
|
|
2024
Q3 | $107K | Sell |
897
-824
| -48% | -$98.3K | 0.01% | 265 |
|
|
2024
Q2 | $246K | Hold |
1,721
| – | – | 0.03% | 191 |
|
|
2024
Q1 | $221K | Sell |
1,721
-6,817
| -80% | -$875K | 0.02% | 212 |
|
|
2023
Q4 | $884K | Buy |
8,538
+8,402
| +6,178% | +$870K | 0.12% | 123 |
|
|
2023
Q3 | $13K | Buy |
+136
| New | +$13K | ﹤0.01% | 321 |
|
|
2016
Q2 | – | Sell |
-1,950
| Closed | -$53K | – | 601 |
|
|
2016
Q1 | $53K | Buy |
+1,950
| New | +$53K | ﹤0.01% | 361 |
|